India’s Reliance Industries Deserves More Patience

[ad_1] The conglomerate, led by Chairman Mukesh Ambani, is in the middle of another growth leap, making shareholders unduly nervous about its shares.  [ad_2] Source link

Auto Insurers’ Rising Rates Are No Accident

[ad_1] Markets Heard on the Street Travelers is pushing to make up for inflated claims costs on personal auto policies [ad_2] Source link

J&J Gets Ready to Break up With Tylenol

[ad_1] Johnson & Johnson’s consumer business was the only division to deliver growth in the fourth quarter. [ad_2] Source link

Google’s Big India Opportunity Faces a Challenge

[ad_1] Markets Heard on the Street A ruling by India’s Supreme Court will force tech giant to make changes in the largest market for its Android operating system [ad_2] Source…

Tesla’s Price Cuts Are Good for Lithium

[ad_1] To follow the money in one of today’s hottest commodity markets, investors should look at company results rather than headline prices. [ad_2] Source link

Procter & Gamble Is No Bargain

[ad_1] P&G shares don’t look attractive as CEO warns of global risks. [ad_2] Source link

Chinese Healthcare Stocks Are an Expensive Bet

[ad_1] Markets Heard on the Street Companies with higher-end products that can compete globally could benefit handsomely from rising healthcare spending [ad_2] Source link

Reinsurers Getting Some Shelter From the Storms

[ad_1] Higher interest rates are curing a capital glut for insurers that backstop other insurers. [ad_2] Source link

Wall Street’s Missing Ingredient: Debt Offerings

[ad_1] In a preview for other investment banks, Jefferies reported solid results with one notable exception. [ad_2] Source link

New Biden Law Won’t Kill Drug Cures. It Will Reshape Them.

[ad_1] Legislation signed by the president in 2022 is likely to affect how pharmaceutical companies allocate capital [ad_2] Source link